Aarkstore Enterprise - Urinary Incontinence - Pipeline Assessment And Market Forecasts To 2017

Aarkstore announce a new report "Urinary Incontinence - Pipeline Assessment and

Market Forecasts to 2017" through its vast collection of market research report.

Summary

The industry analysis specialist, has released its new report, Urinary Incontinence - Pipeline Assessment and Market Forecasts to 2017 is an essential source of information and analysis on the Urinary Incontinence (UI) therapeutics market. The report identifies the key trends shaping and driving the UI market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to significantly shift the positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global UI therapeutics sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

The global Urinary Incontinence (UI) therapeutics market was worth approximately $2.5 billion in 2009. In 2001 the market was valued at $1.4 billion and it grew at an approximate CAGR of 7.8% from 2001 to 2009. The global UI therapeutics market is expected to reach $3.4 billion by 2017 after growing at a CAGR of 3.5%. The impending patent expiries of Detrol and Enablex are the major reasons for the slow market growth expected from 2012 onwards. Presently the therapeutic regimen for UI is dominated by a range of muscarinic receptor antagonists (anticholinergic drugs) which include Detrol/Detrol LA, Ditropan, Enablex, Toviaz, Sanctura XR and VESIcare. This market is a significantly genericized market with many brands across the seven geographies.

Scope

The scope of the report includes:

- Annualized global UI therapeutics market revenues data from 2001 to 2009, forecast for eight years to 2017.

- Geographies covered in this report include the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France and Japan.

- Pipeline analysis data providing an overview of the different phases, mechanisms of action being developed and emerging trends. Key classes of mechanism of action include acetylcholine inhibitors, 3-adrenergic receptor agonists, anticholinergics, TRPV1 antagonists, alpha-agonists, cell therapies, desmopressin formulations, EP 1 receptor antagonists, opioid receptor agonists, vanilloid receptor agonists, delta receptor agonists and NK1 antagonists.

- Analysis of the current and future market competition in the global UI therapeutics market. Key market players covered are Allergan, Inc., Astellas Pharma, Kissei Pharmaceuticals and Pfizer Inc.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs, and the implications for the UI market.

Reasons to buy

The report will enhance and speed up your decision making capability and will allow you to:

- Develop and design your in-licensing and out-licensing strategies through a review of the pipeline products and technologies, and by identifying the companies with the most robust pipelines.

- Develop business strategies by understanding the trends shaping and driving the global UI therapeutics market.

- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to affect the global UI therapeutics market in the future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

- Whats the next big thing in the global UI market landscape? Identify, understand, and capitalize.

For more information, please visit:

http://www.aarkstore.com/reports/Urinary-Incontinence-Pipeline-Assessment-and-Market-Forecasts-to-2017-39938.html

Or email us at press@aarkstore.com or call +919272852585

by: Aarkstore Enterprise

POST COMMENT

Aarkstore Enterprise - Womens Infertility - Pipeline Assessment And Market Forecasts To 2017 Better Risk Management With Market Intelligence Emea Logistics And Express Market Overview - Market Research Report On Aarkstore Enterprise Logistics: Belgium Industry Guide - Market Research Report On Aarkstore Enterprise Stock Market And Painful Investment In Nepal Logistics: United States Industry Guide - Market Research Report On Aarkstore Enterprise Green Consumers in Spain - Market Research Reports On Aarkstore Enterprise Facebook Marketing Secrets Email Marketing – The Mystique Revealed Aarkstore Enterprise--- Global Magnetic Resonance Imaging (mri) Systems Market, 2010 - 2015 Article Marketing What It Is And What It Can Do For You Aarkstore Enterprise--- Global Magnetic Resonance Imaging (mri) Systems Market, 2010 - 2015 Airlines: Advanced Emerging Markets (brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry